Gi-Hoon Nam
Gi-Hoon Nam
ShiftBio Co., Ltd.
Verified email at - Homepage
Cited by
Cited by
Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis
E Koh, EJ Lee, GH Nam, Y Hong, E Cho, Y Yang, IS Kim
Biomaterials 121, 121-129, 2017
Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy
GH Nam, Y Choi, GB Kim, S Kim, SA Kim, IS Kim
Advanced Materials 32 (51), 2002440, 2020
Exosome as a vehicle for delivery of membrane protein therapeutics, PH20, for enhanced tumor penetration and antitumor efficacy
Y Hong, GH Nam, E Koh, S Jeon, GB Kim, C Jeong, DH Kim, Y Yang, ...
Advanced Functional Materials 28 (5), 1703074, 2018
Virus‐mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes
Y Yang, Y Hong, GH Nam, JH Chung, E Koh, IS Kim
Advanced Materials 29 (13), 1605604, 2017
Programmed cell death protein ligand-1 silencing with polyethylenimine–dermatan sulfate complex for dual inhibition of melanoma growth
G Kwak, D Kim, G Nam, SY Wang, IS Kim, SH Kim, IC Kwon, Y Yeo
ACS nano 11 (10), 10135-10146, 2017
Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics
E Cho, GH Nam, Y Hong, YK Kim, DH Kim, Y Yang, IS Kim
Journal of Controlled Release 279, 326-335, 2018
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
S Yang, MK Shim, WJ Kim, J Choi, GH Nam, J Kim, J Kim, Y Moon, ...
Biomaterials 272, 120791, 2021
Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E−/-mice
M Kim, A Sahu, Y Hwang, GB Kim, GH Nam, IS Kim, IC Kwon, G Tae
Biomaterials 226, 119550, 2020
Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
GH Nam, EJ Lee, YK Kim, Y Hong, Y Choi, MJ Ryu, J Woo, Y Cho, DJ Ahn, ...
Nature communications 9 (1), 2165, 2018
Nanocage‐therapeutics prevailing phagocytosis and immunogenic cell death awakens immunity against cancer
EJ Lee, GH Nam, NK Lee, M Kih, E Koh, YK Kim, Y Hong, S Kim, SY Park, ...
Advanced materials 30 (10), 1705581, 2018
Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy
SD Jo, GH Nam, G Kwak, Y Yang, IC Kwon
Nano Today 17, 23-37, 2017
Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis
M Kim, A Sahu, GB Kim, GH Nam, W Um, SJ Shin, YY Jeong, IS Kim, ...
Journal of Controlled Release 269, 337-346, 2018
Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts …
Y Hong, YK Kim, GB Kim, GH Nam, SA Kim, Y Park, Y Yang, IS Kim
Journal of Extracellular Vesicles 8 (1), 1670893, 2019
Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics
NK Lee, EJ Lee, S Kim, G Nam, M Kih, Y Hong, C Jeong, Y Yang, Y Byun, ...
Journal of Controlled Release 267, 172-180, 2017
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
M Kwon, H Jung, GH Nam, IS Kim
Journal of Controlled Release 331, 321-334, 2021
In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic …
S Kim, SA Kim, GH Nam, Y Hong, GB Kim, Y Choi, S Lee, Y Cho, M Kwon, ...
Journal for Immunotherapy of Cancer 9 (1), 2021
Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity
GB Kim, GH Nam, Y Hong, J Woo, Y Cho, IC Kwon, Y Yang, IS Kim
Science Advances 6 (27), eaaz2083, 2020
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer
GH Nam, M Kwon, H Jung, E Ko, SA Kim, Y Choi, SJ Song, S Kim, Y Lee, ...
Journal for ImmunoTherapy of Cancer 9 (7), 2021
Intrinsic cancer vaccination
Y Yang, GH Nam, GB Kim, YK Kim, IS Kim
Advanced Drug Delivery Reviews 151, 2-22, 2019
Functionalized exosome harboring bioactive molecules for cancer therapy
YK Kim, Y Choi, GH Nam, IS Kim
Cancer letters 489, 155-162, 2020
The system can't perform the operation now. Try again later.
Articles 1–20